{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:07:54Z","timestamp":1787933274163,"version":"build-2784847793"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Monkeypox (mpox) is a zoonotic infectious disease caused by the mpox virus. Mpox symptoms are similar to smallpox with less severity and lower mortality. As yet mpox virus is not characterized by as high transmissibility as some severe acute respiratory syndrome 2 (SARS-CoV-2) variants, still, it is spreading, especially among men who have sex with men (MSM). Thus, taking preventive measures, such as vaccination, is highly recommended. While the smallpox vaccine has demonstrated considerable efficacy against the mpox virus due to the antigenic similarities, the development of a universal anti-mpox vaccine remains a necessary pursuit. Recently, nucleic acid vaccines have garnered special attention owing to their numerous advantages compared to traditional vaccines. Importantly, DNA vaccines have certain advantages over mRNA vaccines. In this study, a potentially universal DNA vaccine candidate against mpox based on conserved epitopes was designed and its efficacy was evaluated <jats:italic>via<\/jats:italic> an immunoinformatics approach. The vaccine candidate demonstrated potent humoral and cellular immune responses <jats:italic>in silico<\/jats:italic>, indicating the potential efficacy <jats:italic>in vivo<\/jats:italic> and the need for further research.<\/jats:p>","DOI":"10.3389\/fmicb.2023.1203355","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T12:26:54Z","timestamp":1689942414000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Design, evaluation, and immune simulation of potentially universal multi-epitope mpox vaccine candidate: focus on DNA vaccine"],"prefix":"10.3389","volume":"14","author":[{"given":"Nino","family":"Rcheulishvili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Papukashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng George","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.ijbiomac.2020.06.213","article-title":"Designing a novel mRNA vaccine against SARS-CoV-2: an immunoinformatics approach","volume":"162","author":"Ahammad","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.3390\/v14112374","article-title":"Immunoinformatics-Aided Design of a Peptide Based Multiepitope Vaccine Targeting Glycoproteins and Membrane Proteins against Monkeypox Virus","volume":"14","author":"Akhtar","year":"2022","journal-title":"Viruses"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.4049\/jimmunol.164.3.1625","article-title":"Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses","volume":"164","author":"Alexander","year":"2000","journal-title":"J. Immunol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37070-z","article-title":"Immunoinformatic and systems biology approaches to predict and validate peptide vaccines against Epstein\u2013Barr virus (EBV)","author":"Ali","year":"2019","journal-title":"Sci. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.1038\/s41598-017-09199-w","article-title":"Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection","volume":"7","author":"Ali","year":"2017","journal-title":"Sci. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1126\/science.abj8754","article-title":"Accurate prediction of protein structures and interactions using a 3-track neural network","volume":"373","author":"Baek","year":"2021","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s40203-021-00095-w","article-title":"In silico design of a multi-epitope peptide construct as a potential vaccine candidate for Influenza A based on neuraminidase protein","volume":"9","author":"Behbahani","year":"2021","journal-title":"Silico Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3390\/biomedicines10071464","article-title":"Immune response to SARS-CoV-2 vaccines","volume":"10","author":"Bellamkonda","year":"2022","journal-title":"Biomedicines"},{"key":"B9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41586-021-03365-x","article-title":"Quadrivalent influenza nanoparticle vaccines induce broad protection","volume":"592","author":"Boyoglu-Barnum","year":"2021","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1016\/j.vaccine.2010.07.030","article-title":"A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge","volume":"28","author":"Buchman","year":"2010","journal-title":"Vaccine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0010141","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox\u2014a potential threat? A systematic review","volume":"16","author":"Bunge","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B13","unstructured":"JYNNEOS Vaccine2022"},{"key":"B14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/biologics1030020","article-title":"Nucleic acid vaccines for COVID-19: a paradigm shift in the vaccine development arena","volume":"1","author":"Chavda","year":"","journal-title":"Biologics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1080\/14760584.2021.1987223","article-title":"DNA vaccines for SARS-CoV-2: toward third-generation vaccination era","volume":"20","author":"Chavda","year":"","journal-title":"Expert Rev. Vaccines"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","article-title":"Fusion protein linkers: property, design and functionality","volume":"65","author":"Chen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates","volume":"383","author":"Corbett","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3389\/fimmu.2020.01784","article-title":"Contriving multi-epitope subunit of vaccine for COVID-19: immunoinformatics approaches","volume":"11","author":"Dong","year":"2020","journal-title":"Front. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.vaccine.2006.09.032","article-title":"Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties","volume":"25","author":"Doytchinova","year":"","journal-title":"Vaccine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"","journal-title":"BMC Bioinform."},{"key":"B21","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3389\/fimmu.2013.00354","article-title":"Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants","volume":"4","author":"Flingai","year":"2013","journal-title":"Front. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1385\/1-59259-890-0:571","article-title":"Protein identification and analysis tools on the ExPASy server; the proteomics protocols handbook","volume":"112","author":"Gasteiger","year":"2005","journal-title":"Humana Press"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e36100","DOI":"10.2196\/36100","article-title":"Development of a multiepitope vaccine against SARS-CoV-2: immunoinformatics study","volume":"3","author":"Ghafouri","year":"2022","journal-title":"JMIR Bioinforma. Biotechnol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data","volume":"397","author":"Haas","year":"2021","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/nar\/gkt458","article-title":"GalaxyRefine: protein structure refinement driven by side-chain repacking","volume":"41","author":"Heo","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","article-title":"Subunit recombinant vaccine protects against monkeypox","volume":"177","author":"Heraud","year":"2022","journal-title":"J. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jinf.2022.05.028","article-title":"Transmission of monkeypox virus through sexual contact \u2013 a novel route of infection","volume":"85","author":"Heskin","year":"2022","journal-title":"J. Infect."},{"key":"B28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/infdis\/jiq017","article-title":"Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge","volume":"203","author":"Hirao","year":"2011","journal-title":"J. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.3390\/ijms19113605","article-title":"DNA vaccines\u2014how far from clinical use?","volume":"19","author":"Hobernik","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J. Virol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1128\/AAC.47.9.2804-2809.2003","article-title":"Antimicrobial characterization of human \u03b2-defensin 3 derivatives","volume":"47","author":"Hoover","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"B32","first-page":"2022","article-title":"Monkeypox in humans: a new outbreak","volume":"6","author":"Javier","year":"2022","journal-title":"Off. J. Spanish Soc. Chemother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","article-title":"BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes","volume":"45","author":"Jespersen","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/infdis\/156.2.293","article-title":"Human monkeypox: clinical features of 282 patients","volume":"156","author":"Jezek","year":"1987","journal-title":"J. Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","first-page":"110206","DOI":"10.1016\/j.intimp.2023.110206","article-title":"Efficacy of the modified vaccinia Ankara virus vaccine and the replication-competent vaccine ACAM2000 in monkeypox prevention Mahmoud","volume":"119","author":"Kandeel","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0253393","DOI":"10.1371\/journal.pone.0253393","article-title":"Immunoinformatics and molecular dynamics approaches: next generation vaccine design against West Nile virus","volume":"16","author":"Khan","year":"2021","journal-title":"PLoS ONE"},{"key":"B38","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.3390\/ijms23147866","article-title":"Monkeypox: a new threat?","volume":"23","author":"Kmiec","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/vaccines9040390","article-title":"mRNA-based vaccines","volume":"9","author":"Kowalzik","year":"2021","journal-title":"Vaccines"},{"key":"B40","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein-protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat. Protoc."},{"key":"B41","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/d41586-022-01493-6","article-title":"Monkeypox outbreaks: 4 key questions researchers have","volume":"606","author":"Kozlov","year":"2022","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3201\/eid2002.130118","article-title":"Genomic variability of monkeypox virus among humans, democratic Republic of the Congo","volume":"20","author":"Kugelman","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"783527","DOI":"10.3389\/fcell.2021.783527","article-title":"Identification of tumor antigens and design of mRNA vaccine for colorectal cancer based on the immune subtype","volume":"9","author":"Liu","year":"","journal-title":"Front. Cell Dev. Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3390\/pharmaceutics14051101","article-title":"Development of an LNP-Encapsulated mRNA-RBD vaccine against SARS-CoV-2 and its variants","volume":"14","author":"Liu","year":"","journal-title":"Pharmaceutics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1091\/mbc.11.7.2497","article-title":"Entry of the two infectious forms of vaccinia virus at the plasma membane is signaling-dependent for the IMV but not the EEV","volume":"11","author":"Locker","year":"2000","journal-title":"Mol. Biol. Cell"},{"key":"B46","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","article-title":"Monkeypox: disease epidemiology, host immunity and clinical interventions","volume":"22","author":"Lum","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.1128\/jvi.61.12.3910-3919.1987","article-title":"Structural and functional studies of a 39,000-Mr immunodominant protein of vaccinia virus","volume":"61","author":"Maa","year":"1987","journal-title":"J. Virol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1080\/07391102.2019.1647286","article-title":"Contriving a chimeric polyvalent vaccine to prevent infections caused by herpes simplex virus (Type-1 and Type-2): an exploratory immunoinformatic approach","volume":"38","author":"Mahmudul","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B49","doi-asserted-by":"publisher","first-page":"100044","DOI":"10.1016\/j.health.2022.100044","article-title":"In silico vaccine design: a tutorial in immunoinformatics","volume":"2","author":"Martinelli","year":"2022","journal-title":"Healthc. Anal."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2200471","DOI":"10.2807\/1560-7917.ES.2022.27.27.2200471","article-title":"Monkeypox outbreak predominantly affecting men who have sex with men, Madrid, Spain, 26 April to 16 June 2022","volume":"27","author":"Mart\u00ednez","year":"2022","journal-title":"Eurosurveillance"},{"key":"B51","first-page":"889","article-title":"Smallpox vaccine: contraindications, administration, and adverse reactions","volume":"68","author":"Maurer","year":"2003","journal-title":"Am. Fam. Physician"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1093\/bioinformatics\/btz029","article-title":"AllerCatPro-prediction of protein allergenicity potential from the protein sequence","volume":"35","author":"Maurer-Stroh","year":"2019","journal-title":"Bioinformatics"},{"key":"B53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/14760584.2021.1991794","article-title":"SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways","volume":"21","author":"Mekonnen","year":"2022","journal-title":"Expert Rev. Vaccines"},{"key":"B54","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.virol.2018.03.005","article-title":"Characterization of murine antibody responses to vaccinia virus envelope protein A14 reveals an immunodominant antigen lacking of effective neutralization targets","volume":"518","author":"Meng","year":"2018","journal-title":"Virology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1128\/JCM.40.8.2919-2921.2002","article-title":"Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001","volume":"40","author":"Meyer","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"102386","DOI":"10.1016\/j.tmaid.2022.102386","article-title":"New challenges in human monkeypox outside Africa: a review and case report from Italy","volume":"49","author":"Mileto","year":"2022","journal-title":"Travel Med. Infect. Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","article-title":"ColabFold: making protein folding accessible to all","volume":"19","author":"Mirdita","year":"2022","journal-title":"Nat. Methods"},{"key":"B58","doi-asserted-by":"publisher","first-page":"102417","DOI":"10.1016\/j.tmaid.2022.102417","article-title":"Hospitalisation for monkeypox in Milan, Italy","volume":"49","author":"Moschese","year":"2022","journal-title":"Travel Med. Infect. Dis."},{"key":"B59","author":"Nelson","year":"2021","journal-title":"Lehninger Principles of Biochemistry"},{"key":"B60","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jtbi.2014.01.018","article-title":"A novel multi-epitope peptide vaccine against cancer: an in silico approach","volume":"349","author":"Nezafat","year":"2014","journal-title":"J. Theor. Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"W36","DOI":"10.1093\/nar\/gkac446","article-title":"AllerCatPro 2.0: a web server for predicting protein allergenicity potential","volume":"50","author":"Nguyen","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"587615","DOI":"10.3389\/fimmu.2020.587615","article-title":"Immunoinformatic analysis of SARS-CoV-2 nucleocapsid protein and identification of COVID-19 vaccine targets","volume":"11","author":"Oliveira","year":"2020","journal-title":"Front. Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jinf.2022.07.005","article-title":"Monkeypox outbreak in Madrid (Spain): clinical and virological aspects","volume":"85","author":"Orviz","year":"2022","journal-title":"J. Infect."},{"key":"B64","doi-asserted-by":"publisher","first-page":"12884","DOI":"10.3390\/ijms232112884","article-title":"Self-amplifying RNA approach for protein replacement therapy","volume":"23","author":"Papukashvili","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1050309","DOI":"10.3389\/fimmu.2022.1050309","article-title":"Strategy of developing nucleic acid-based universal monkeypox vaccine candidates","volume":"13","author":"Papukashvili","year":"","journal-title":"Front. Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines-a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B67","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinform."},{"key":"B68","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/vaccines8020288","article-title":"Multiepitope-based subunit vaccine design and evaluation against respiratory syncytial virus using reverse vaccinology approach","volume":"8","author":"Qamar","year":"2020","journal-title":"Vaccines"},{"key":"B69","doi-asserted-by":"publisher","first-page":"633776","DOI":"10.3389\/fcell.2021.633776","article-title":"A guide to nucleic acid vaccines in the prevention and treatment of infectious diseases and cancers: from basic principles to current applications","volume":"9","author":"Qin","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.21203\/rs.3.rs-92515\/v1","article-title":"Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2","volume":"40","author":"Rahmani","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"Rapin","year":"2010","journal-title":"PLoS ONE"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1093\/bioinformatics\/btr335","article-title":"Immune system simulation online","volume":"27","author":"Rapin","year":"2011","journal-title":"Bioinformatics"},{"key":"B73","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature10124","article-title":"A 2020 vision for vaccines against HIV, tuberculosis and malaria","volume":"473","author":"Rappuoli","year":"2011","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ijbiomac.2022.12.066","article-title":"Designing multi-epitope mRNA construct as a universal influenza vaccine candidate for future epidemic\/pandemic preparedness","volume":"226","author":"Rcheulishvili","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1025884","DOI":"10.3389\/fimmu.2022.1025884","article-title":"Promising strategy for developing mRNA-based universal influenza virus vaccine for human population, poultry, and pigs\u2013 focus on the bigger picture","volume":"13","author":"Rcheulishvili","year":"2022","journal-title":"Front. Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B77","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9121078","article-title":"Computational analysis of african swine fever virus protein space for the design of an epitope-based vaccine ensemble","author":"Ros-Lucas","year":"2020","journal-title":"Pathogens"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.ymthe.2019.05.012","article-title":"mRNA delivery for therapeutic Anti-HER2 antibody expression in vivo","volume":"27","author":"Rybakova","year":"2019","journal-title":"Mol. Ther."},{"key":"B79","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3390\/pathogens11080924","article-title":"Monkeypox and its possible sexual transmission: where are we now with its evidence?","volume":"11","author":"Sah","year":"2022","journal-title":"Pathogens"},{"key":"B80","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S0140-6736(22)01487-8","article-title":"Evidence of human-to-dog transmission of monkeypox virus","volume":"400","author":"Seang","year":"2022","journal-title":"Lancet"},{"key":"B81","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2217\/fvl-2021-0170","article-title":"A brief review on DNA vaccines in the era of COVID-19","volume":"17","author":"Shafaati","year":"2022","journal-title":"Future Virol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s15010-022-01935-3","article-title":"State-of-the-art on monkeypox virus: an emerging zoonotic disease","volume":"50","author":"Shafaati","year":"2022","journal-title":"Infection"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e28251","DOI":"10.1002\/jmv.28251","article-title":"Human monkeypox (hMPXV) re-emergence: host immunity status and current vaccines landscape","volume":"95","author":"Shafaati","year":"2023","journal-title":"J. Med. Virol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"152053","DOI":"10.1016\/j.imbio.2021.152053","article-title":"Immunoinformatics approach for a novel multi-epitope subunit vaccine design against various subtypes of Influenza A virus","volume":"226","author":"Sharma","year":"2021","journal-title":"Immunobiology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1006\/viro.2002.1446","article-title":"Analysis of the monkeypox virus genome","volume":"197","author":"Shchelkunov","year":"2002","journal-title":"Virology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/d41587-021-00023-5","article-title":"First COVID-19 DNA vaccine approved, others in hot pursuit","volume":"39","author":"Sheridan","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"118919","DOI":"10.1016\/j.lfs.2020.118919","article-title":"DNA vaccines against COVID-19: Perspectives and challenges","volume":"267","author":"Silveira","year":"2021","journal-title":"Life Sci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fpubh.2018.00241","article-title":"Emergence of monkeypox as the most important orthopoxvirus infection in humans","volume":"6","author":"Sklenovsk\u00e1","year":"2018","journal-title":"Front. Public Heal."},{"key":"B89","doi-asserted-by":"publisher","first-page":"24485","DOI":"10.1038\/s41598-021-03932-2","article-title":"Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9","volume":"11","author":"Tarrahimofrad","year":"2021","journal-title":"Sci. Rep."},{"key":"B90","doi-asserted-by":"publisher","first-page":"10768","DOI":"10.1038\/s41598-022-15073-1","article-title":"Nanopore sequencing of a monkeypox virus strain isolated from a pustular lesion in the Central African Republic","volume":"12","author":"Vandenbogaert","year":"2022","journal-title":"Sci. Rep."},{"key":"B91","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/pharmaceutics15010166","article-title":"mRNA in the context of protein replacement therapy","volume":"15","author":"Vavilis","year":"2023","journal-title":"Pharmaceutics"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and immunogenicity of Two RNA-based Covid-19 vaccine candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12915-023-01510-8","article-title":"Prediction of protein solubility based on sequence physicochemical patterns and distributed representation information with DeepSoluE","volume":"21","author":"Wang","year":"2023","journal-title":"BMC Biol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41541-023-00672-4","article-title":"Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa","volume":"8","author":"Wang","year":"2023","journal-title":"npj Vaccines"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3390\/v14051049","article-title":"Development of DNA vaccine candidate against SARS-CoV-2","volume":"14","author":"Wang","year":"2022","journal-title":"Viruses"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview Version 2-a multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics"},{"key":"B97","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/vaccines1030225","article-title":"Vector design for improved DNA vaccine efficacy, safety and production","volume":"1","author":"Williams","year":"2013","journal-title":"Vaccines"},{"key":"B98","unstructured":"Monkeypox"},{"key":"B99","volume-title":"WHO Director-General Declares the Ongoing Monkeypox Outbreak a Public Health Emergency of International Concern","year":""},{"key":"B100","doi-asserted-by":"publisher","first-page":"e2110817118","DOI":"10.1073\/pnas.2110817118","article-title":"An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination","volume":"118","author":"Xia","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B101","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1002\/jmv.27884","article-title":"Monkeypox: a potential global threat?","volume":"94","author":"Yang","year":"2022","journal-title":"J. Med. Virol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1016\/j.vaccine.2005.01.031","article-title":"An ingenious design for peptide vaccines","volume":"23","author":"Yano","year":"2005","journal-title":"Vaccine"},{"key":"B103","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-022-02090-w","article-title":"Low levels of monkeypox virus neutralizing antibodies after MVA-BN vaccination in healthy individuals","volume":"29","author":"Zaeck","year":"2022","journal-title":"Nat. Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1106247","DOI":"10.3389\/fmicb.2023.1106247","article-title":"Mechanisms of immune evasion of monkeypox virus","volume":"14","author":"Zandi","year":"2023","journal-title":"Front. Microbiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.str.2011.09.022","article-title":"Atomic-level protein structure refinement using fragment guided molecular dynamics conformation sampling","volume":"19","author":"Zhang","year":"2011","journal-title":"Structure"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2192815","DOI":"10.1080\/22221751.2023.2192815","article-title":"Rational development of multicomponent mRNA vaccine candidates against mpox","volume":"12","author":"Zhang","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"B107","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11684-022-0952-z","article-title":"Unusual global outbreak of monkeypox: what should we do?","volume":"16","author":"Zhu","year":"2022","journal-title":"Front. Med."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1203355\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T12:27:03Z","timestamp":1689942423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1203355\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":107,"alternative-id":["10.3389\/fmicb.2023.1203355"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2023.1203355","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"article-number":"1203355"}}